Grid Exponential

SphereBio, established in 2023, specializes in developing biotechnology platforms that facilitate the delivery of molecules to cells, thereby training them to respond to specific health issues. The company leverages its platforms to provide pharmaceutical and veterinary businesses with innovative methods to enhance vaccines and therapeutics, tailored to combat diseases like cancer.

MicroIN is a biotechnology company that specializes in enhancing the stability and effectiveness of biological products, particularly in the agro-environmental sector. It achieves this by developing customized encapsulation protocols for microorganisms, improving their viability and optimizing bioinput formulations.

Polymera leverages the adaptive mechanisms of an extremophile antarctic bacterium to develop naturally biodegradable biopolymers.

MIGMA uses Artificial Intelligence to accelerate the discovery of new synergistic combinations of antioxidants.

BioBlends develops biopreservatives for the food industry to extend the shelf life of food products.

Apasomics is a biotechnology company specializing in bone-targeted drug delivery. It develops apasome-based nanocarriers to deliver bisphosphonates directly to bones, enhancing treatment efficacy for osteoporosis and other skeletal disorders while minimizing side effects. By combining nanotechnology and precision medicine, Apasomics aims to improve therapeutic outcomes and patient quality of life.

GlycoX is a biotechnology company specializing in innovative diabetes management solutions. It develops an oral solution aimed at controlling blood sugar levels, empowering diabetic patients and improving their quality of life. The company's approach combines natural elements with advanced technology, aiming to revolutionize diabetes treatment.

Nanoingreen specializes in transforming plant-based products into functional foods. Utilizing precision fermentation processes, they offer formulations that enhance the nutritional value of these products, preventing future health issues.

APEXzymes focuses on developing microbial technologies for industrial production of biofertilizers and enzymes. It builds enzyme production platforms using genetic engineering and fermentation to create high-performance enzymes at lower cost, and provides advanced enzyme formulations optimized for cost-efficiency and scalability. These offerings support biofuel production and animal nutrition by improving sustainability and reducing expenses, while increasing operational viability.

Dogma BioTech is a biotechnology firm that develops protein-based therapeutics.

AlgaLife is a biotechnology company that focuses on improving microalgae cultivation processes, enabling 95% cheaper production costs while maintaining high yields. The company's core product is a microalgae consortium designed to enhance aquaculture efficiency and sustainability. This consortium improves gut health and immunological activity in farmed aquatic animals, reducing mortality rates and enabling the aquaculture industry to meet sustainability challenges more effectively.

Ocular Bio Design is a tissue engineering company for the regeneration of visual function.

Smart delivery biocapsules that enhance crop production.

Aquit is a biotechnology company specializing in the development of preventive treatments for fish infections. Their innovative solutions aim to replace antibiotics, thereby enhancing fish immunity, improving survival rates, and promoting sustainable aquaculture practices.

Gisens Biotech is a biotechnology company focused on bioelectronics and nanotechnology, developing portable diagnostics such as the Nano-Lab, a device that provides real-time measurements of biomarkers from tiny samples of blood, urine, or saliva. The Nano-Lab aims to deliver accurate, portable biomarker analysis and interpretation, potentially changing how measurements are performed. The company is also pursuing a nanotechnology-based platform to diagnose and monitor renal biomarkers—urea, creatinine, and potassium—from a single blood drop, with results accessible through an application for real-time health monitoring.

Eywa is a biotechnology company specializing in the development of innovative production methods for psychedelic medicines. It focuses on designing efficient processes and products to enhance the adoption of these treatments, leveraging biosynthesis to create patient-centered therapies aimed at improving mental health outcomes.

Fungi Life is a biotechnology company specializing in the production of biosurfactants using innovative fungal biotechnology. It aims to replace synthetic surfactants across various industries, including oil and gas, cleaning, cosmetics, agriculture, and personal care, promoting sustainability and reduced environmental impact.

UpDairy is a food technology company specializing in the development of alternative dairy proteins. It employs precision fermentation using microorganisms to produce dairy proteins without relying on animals, thereby reducing greenhouse gas emissions and offering customers environmentally friendly alternatives.

Kresko RNAtech is a biotechnology company specializing in the development and production of nutraceuticals. It employs advanced techniques such as machine learning and bioinformatics to identify beneficial ribonucleic acids (RNAs) from natural sources, aiming to enhance human health and well-being.

Nanotransfer develops non-viral delivery systems for nucleic acids, offering versatility, biosafety, specificity, scalability, and low cost. These systems facilitate cellular internalization and can be tailored to target specific cells.

Cryosmetics specializes in the development of natural skincare products. Its focus is on promoting skin health by maintaining the balance of the skin's microbiome through preservative-free and synthetic chemical-free formulas.

Fecundis is a biotechnology company based in Rosario, Argentina, specializing in reproductive biology. It develops innovative solutions aimed at improving sperm competence and enhancing success rates in assisted reproductive technologies.

CASPR Biotech is a San Francisco-based company established in 2018 that specializes in the development of a CRISPR-based platform for diagnosing antimicrobial resistances (AMR) and infectious diseases. The company focuses on creating portable diagnostic kits that utilize proprietary CRISPR Cas enzymes to detect specific DNA and RNA sequences, as well as signature amino acid sequences associated with infectious diseases and genetic mutations. These kits are designed to provide clinicians with a simple, fast, and affordable solution for molecular detection, enhancing the efficiency of disease identification in clinical and hospital settings.

Feedvax is an innovative company based in Argentina, established in 2018, focused on developing a platform for oral vaccines aimed at improving animal health in aquaculture. Its primary product is an oral vaccine designed to protect farmed tilapia from streptococcosis, a common disease affecting this widely farmed species. Feedvax's platform not only delivers vaccines but also provides a smart feeder that ensures nutritional and health treatments are administered automatically and individually to each animal. The company's solution is environmentally safe, cost-effective, and easy for farmers to use, promoting greater efficiency in animal production while helping to eliminate the need for antibiotics and reducing stress on the fish. By transforming traditional aquaculture practices, Feedvax aims to make a sustainable impact on the industry.

Algaebio+ is a company based in Argentina that specializes in the production of natural astaxanthin, a powerful antioxidant derived from the microalga Haematococcus pluvialis. This product is designed to offer a range of health benefits, including immunoregulatory, anti-inflammatory, and photo-protective properties, as well as potential applications in anti-aging and cancer prevention. Algaebio+ cultivates astaxanthin under controlled laboratory conditions before transitioning the production to photobioreactors. The company's offerings target various industries, including pharmaceuticals, nutraceuticals, functional foods, and cosmetics, where they aim to replace artificial pigments with their natural product. Additionally, astaxanthin is known to support joint, muscle, vision, and heart health, contributing to more effective treatments for chronic diseases.

Aplife Biotech is an Argentine biotechnology startup founded in 2018, based in Buenos Aires. The company focuses on developing innovative technologies for the high-throughput discovery of novel aptamers, which are synthetic DNA-derived molecules used in biosensors. Aplife Biotech's platform enables the manufacture of large combinatorial libraries of these aptamers in predefined locations, facilitating the mass screening of important biological molecules. This technology addresses global challenges in medical diagnostics by supporting the creation of novel biosensors and diagnostic assays, as well as therapeutic applications.